Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Arthritis Care Res (Hoboken) ; 73(4): 586-592, 2021 04.
Article in English | MEDLINE | ID: mdl-32886859

ABSTRACT

OBJECTIVE: To report the cumulative articular and extraarticular damage in Arab children with juvenile idiopathic arthritis (JIA) and to identify variables that correlate with disease damage. METHODS: We conducted a multicenter, cross-sectional study among 14 pediatric rheumatology centers from 7 Arab countries. JIA patients who met the International League of Associations for Rheumatology classification criteria and had a disease duration of >1 year were enrolled. Disease activity status was assessed using the Juvenile Arthritis Multidimensional Assessment Report. Disease damage was assessed by the Juvenile Arthritis Damage Index, articular (JADI-A) and extraarticular (JADI-E). RESULTS: A total of 702 (471 female) JIA patients with a median age of 11.3 years (interquartile range [IQR] 8.0-14.0 years) were studied. Median age at disease onset was 5 years (IQR 2.0-9.0 years) and the median disease duration was 4 years (IQR 2.0-7.0 years). The most frequent JIA categories were oligoarticular JIA (34.9%), polyarticular JIA (29.5%), and systemic JIA (24.5%). Clinical remission was achieved in 73.9% of patients. At the last clinic visit, 193 patients experienced joint damage, with a mean ± SD JADI-A score of 1.7 ± 4.5, while 156 patients had extraarticular damage, with a mean ± SD JADI-E score of 0.5 ± 1.1. Patients with enthesitis-related arthritis had the highest JADI-A score. JADI-A correlated significantly with the presence of a family history of JIA. JADI-A and JADI-E had a significant correlation with long disease duration. CONCLUSION: Cumulative damage was common in this Arab JIA cohort, and consanguinity and JIA in a sibling were frequent findings and were associated with a greater cumulative damage.


Subject(s)
Arthritis, Juvenile/diagnostic imaging , Joints/diagnostic imaging , Adolescent , Age of Onset , Antirheumatic Agents/therapeutic use , Arabs/genetics , Arthritis, Juvenile/drug therapy , Arthritis, Juvenile/ethnology , Arthritis, Juvenile/genetics , Child , Child, Preschool , Consanguinity , Cross-Sectional Studies , Female , Heredity , Humans , Joints/drug effects , Male , Middle East/epidemiology , Pedigree , Predictive Value of Tests , Remission Induction , Risk Factors , Severity of Illness Index , Treatment Outcome
2.
Rheumatol Int ; 40(1): 49-56, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31741047

ABSTRACT

To define the spectrum and phenotypic characteristics of systemic autoinflammatory diseases (SAIDs) other than familial Mediterranean fever (FMF) in Arab children and to delineate diagnostic evaluation. Data retrospectively collected on patients with clinical and/or genetically proven SAIDs other than FMF at 10 tertiary Arab pediatric rheumatology clinics from 1990 to 2018. The collected data comprised the clinical findings and diagnostic evaluation including genetic testing, the provided treatment and the accrual damage related to SAIDs. A total of 144 patients (93 female) with a median age at onset of 2.5 (range 0.1-12) years were enrolled. The initial diagnosis was inaccurate in 49.3%. Consanguinity rate among parents was 74.6%. The median time-to-diagnosis for all SAIDs was 2.5 (range 0.1-10) years. There were 104 patients (72.2%) with a confirmed diagnosis and 40 patients with suspected SAIDs. Seventy-two had monogenic and 66 patients with multifactorial SAIDs while six patients had undifferentiated SAIDs. The most frequent monogenic SAIDs were LACC1 mediated monogenic disorders (n = 23) followed by CAPS (12), TRAPS (12), HIDS (12), and Majeed's syndrome (6). The most frequent multifactorial SAIDs was CRMO (34), followed by PFAPA (18), and early onset sarcoidosis (EOS) (14). Genetic analysis was performed in 69 patients; 50 patients had genetically confirmed disease. Corticosteroid used for 93 patients while biologic agents for 96 patients. Overall, growth failure was the most frequent accrual damage (36%), followed by cognitive impairment (13%). There were three deaths because of infection. This study shows a heterogenous spectrum of SAIDs with a high number of genetically confirmed monogenic diseases; notably, LACC1 associated diseases. Hopefully, this work will be the first step for a prospective registry for SAIDs in Arab countries.


Subject(s)
Hereditary Autoinflammatory Diseases/diagnosis , Hereditary Autoinflammatory Diseases/epidemiology , Acne Vulgaris/diagnosis , Acne Vulgaris/drug therapy , Acne Vulgaris/epidemiology , Acne Vulgaris/physiopathology , Adolescent , Anemia, Dyserythropoietic, Congenital/diagnosis , Anemia, Dyserythropoietic, Congenital/drug therapy , Anemia, Dyserythropoietic, Congenital/epidemiology , Anemia, Dyserythropoietic, Congenital/physiopathology , Antirheumatic Agents/therapeutic use , Arabs , Arthritis/diagnosis , Arthritis/drug therapy , Arthritis/epidemiology , Arthritis/physiopathology , Arthritis, Infectious/diagnosis , Arthritis, Infectious/drug therapy , Arthritis, Infectious/epidemiology , Arthritis, Infectious/physiopathology , Arthritis, Juvenile/drug therapy , Arthritis, Juvenile/epidemiology , Arthritis, Juvenile/genetics , Arthritis, Juvenile/physiopathology , Bahrain/epidemiology , Child , Child, Preschool , Consanguinity , Crohn Disease/drug therapy , Crohn Disease/epidemiology , Crohn Disease/genetics , Crohn Disease/physiopathology , Cross-Sectional Studies , Cryopyrin-Associated Periodic Syndromes/diagnosis , Cryopyrin-Associated Periodic Syndromes/drug therapy , Cryopyrin-Associated Periodic Syndromes/epidemiology , Cryopyrin-Associated Periodic Syndromes/physiopathology , Diagnostic Errors , Female , Fever/diagnosis , Fever/drug therapy , Fever/epidemiology , Fever/physiopathology , Hereditary Autoinflammatory Diseases/drug therapy , Hereditary Autoinflammatory Diseases/physiopathology , Humans , Immunologic Deficiency Syndromes/diagnosis , Immunologic Deficiency Syndromes/drug therapy , Immunologic Deficiency Syndromes/epidemiology , Immunologic Deficiency Syndromes/physiopathology , Infant
SELECTION OF CITATIONS
SEARCH DETAIL